Patents Assigned to ReproPharm
  • Ligands that potentiate the bioactivity of gonadotropins
    Patent number: 10584166
    Abstract: The invention relates to antibodies directed against follicle-stimulating hormone (FSH) and capable of potentiating the bioactivity of gonadotropins.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: March 10, 2020
    Assignee: REPROPHARM VET
    Inventors: Elodie Kara, Jeremye Decourtye, Sophie Casteret, Marie-Christine Maurel
  • LIGANDS THAT POTENTIATE THE BIOACTIVITY OF GONADOTROPINS
    Publication number: 20170190774
    Abstract: The invention relates to antibodies directed against follicle-stimulating hormone (FSH) and capable of potentiating the bioactivity of gonadotropins.
    Type: Application
    Filed: September 10, 2015
    Publication date: July 6, 2017
    Applicant: Repropharm
    Inventors: Elodie KARA, Jeremye Decourtye, Sophie Casteret, Marie-Christine Maurel
  • Method and kit for detecting the preovulatory LH peak
    Patent number: 9206254
    Abstract: The present invention relates to a method of detecting the preovulatory LH peak in a biological sample obtained from mammals and a kit for applying the method of detection. The present invention finds application notably in the veterinary and medical areas.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: December 8, 2015
    Assignee: REPROPHARM
    Inventors: Jeremy Decourtye, Laurence Dupuy, Elodie Kara, Marie-Christine Maurel
  • METHOD AND KIT FOR DETECTING THE PREOVULATORY LH PEAK
    Publication number: 20140134649
    Abstract: The present invention relates to a method of detecting the preovulatory LH peak in a biological sample obtained from mammals and a kit for applying the method of detection. The present invention finds application notably in the veterinary and medical areas.
    Type: Application
    Filed: April 12, 2013
    Publication date: May 15, 2014
    Applicant: ReproPharm
    Inventor: ReproPharm